Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0018801 (heart failure)
 72,216 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

An acute tolerance test per os using calcium (Ca) lactate at a dose of 0.25 mmol of Ca per kg of body mass (calcium tolerance test--CTT) was performed twice in healthy persons (HP) and in patients with chronic heart failure (CHF) of various degrees: before and after 3-day administration of the same dose of Ca lactate. The "double" CTT made it possible to detect in HP and CHF a "phenomenon of adaptation" to Ca excess in the body based probably on changes in the activity of calcium-regulating hormones. It was manifested in less marked and prolonged tolerance hypercalcemia and a more rapid and effective calciuretic reaction, and probably in decreased intestinal absorption of Ca. It pointed to reversibility of Ca metabolic derangements even in severe CHF and a possibility of their non-medicamentous correction.
 ...
PMID:[Assessment of the calcium homeostatic state using the double calcium tolerance test]. 324 51

Transcranial color-coded sonography (TCCS) has been used to investigate major brain-supplying arteries, draining veins and brain parenchyma. Here, we describe a contrast-enhanced TCCS analysis of cerebral arteriovenous transit time (cTT) as a measure of cerebral microcirculation. We evaluate its reproducibility and its correlation with clinical impairment of brain function and neuropsychological tests. A total of 27 patients with cerebral microangiopathy and 30 healthy controls were examined. CTT is defined by the time an ultrasound contrast agent requires to pass from the P2-segment of the posterior cerebral artery to the vein of Galen. This was measured by comparison of power Doppler intensity in two off-line defined regions of interest. Serial intraindividual cTT measurements within several min showed a good reproducibility of this parameter. cTT was significantly longer in patients with cerebral microangiopathy than in controls (Mann-Whitney U test,p < 0.001) and related to cognitive impairment measured by the Mini-Mental-State examination. We conclude that it is a quick and reliable parameter related to increased vascular resistance of the microcirculation or a rarefaction of microvessels. Further studies are needed to show the sensitivity and specificity of cTT in the diagnosis of small vessel disease and the interference of important circulation factors, such as heart failure or blood viscosity.
 ...
PMID:Cerebral arteriovenous transit time (CTT): a sonographic assessment of cerebral microcirculation using ultrasound contrast agents. 1038 24